Effectiveness and Safety of Varying Doses of Linezolid With Bedaquiline and Pretomanid in Treatment of Drug-Resistant Pulmonary Tuberculosis: Open-Label, Randomized Clinical Trial.

Padmapriyadarsini ChandrasekaranVikas S OswalChetankumar D JainMuthu Vijayalakshmi MariappanNeeta SinglaSantosh KumarBella Devaleenal DanielJigna D DaveParul VadgamaBalaji RamrajSurya KantAnuj K BhatnagarSivakumar ShanmugamDhamodharan PaulJeyadeepa BharathiManasi PalavNeha V ShahRameshkumar SanthanakrishnanRavindra K DewanNadim ShekhPrabhakaran RathinamArvind B SisaraShubhangi Dhakulkar MankarJyoti BajpaiUpasana MittalSandeep ChauhanRavinder KumarMallik ParmarSanjay K MattooJyoti Jajunull null

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)

Clinical Trial Registry of India (CTRI/2021/03/032189).

Keyphrases

drug resistant
pulmonary tuberculosis
clinical trial
open label
multidrug resistant
acinetobacter baumannii
mycobacterium tuberculosis
phase ii
double blind
study protocol
phase iii
phase ii study
methicillin resistant staphylococcus aureus
squamous cell carcinoma
randomized controlled trial
cystic fibrosis